GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

On election day, Tuesday, November 5, Americans will choose between former President Donald Trump and current Vice President ...

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

Biopharma leaders at companies developing blood cancer therapies say we shouldn’t be afraid to use the four-letter word: cure ...

Morgan Stanley lowered the firm’s price target on Zenas BioPharma (ZBIO) to $35 from $40 and keeps an Overweight rating on the shares. The firm ...

Veradermics Inc., a New Haven-based biopharmaceutical company, said Wednesday it has closed a $75 million Series B financing ...

ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ophthalmology, CNS (central nervous system), and oncology/hematology, announced the ...

With the China-targeting Biosecure Act absent from a key defense spending bill revealed over the weekend, it appears the ...

Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...

As part of an SEC settlement, a Houston pharmaceutical company won't have to pay a civil penalty — but two of its former top ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...